Tag: COVID-19

Novavax’s COVID-19 vaccine received FDA AdCom approval, clearing “serious hurdles”

Global Markets Techno - 08.06.2022

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, Tuesday announced the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Regulatory Techno - 24.05.2022

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Regulatory Techno - 17.05.2022

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Australian Biotron’s share price rose 38% due to COVID-19 study results

Global Markets Techno - 02.05.2022

Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today. Biotron...

New study shows, longer intervals between COVID-19 vaccinations result in 9 times more protective antibodies

Drug Development Techno - 25.04.2022

New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold....

FDA grants Regenerative Medicine Advanced Therapy designation to Direct Biologics’ extracellular vesicle drug for Covid-19

Global Markets Techno - 15.04.2022

Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S....

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

Drug Development Techno - 14.04.2022

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for...

Veru’s new drug COVID-19 reduces deaths by 55% among hospitalized patients in an interim analysis of a phase 3 study

Global Markets Techno - 12.04.2022

Veru Inc., an oncology biopharmaceutical company, April 11th announced positive efficacy and safety results of Phase 3 COVID-19 clinical...

CureVac and GSK contract with German government enabling rapid availability of 80 million mRNA-based vaccine

Global Markets Techno - 11.04.2022

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”),...

Deliberate COVID-19 infection trial finds symptoms don’t indicate viral shedding

Global Markets Techno - 01.04.2022

The world's first "human challenge" trial in which volunteers were deliberately exposed to the coronavirus has found that symptoms...

HIV antiviral drugs may protect against COVID-19 infection

Global Markets Techno - 29.03.2022

According to a new study, some antiviral drugs used to treat HIV may also protect against COVID-19 infection. A preliminary...

Visby Medical contracts with BARDA to develop the Flu-COVID rapid all-in-one PCR test for home use

Drug Development Techno - 28.03.2022

Visby Medical™, a leading medical diagnostic company, announced that it has received an additional $25.5M in federal funding to...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Hot topics

Finance

Marketing

Politics

Strategy

Hot topics

Finance

Marketing

Politics

Strategy

Tag: COVID-19

Company

Headlines

Newsletter